Spelling suggestions: "subject:"kidney neoplasias"" "subject:"sidney neoplasias""
1 |
Novel cancer therapeutics, the generation of ROS, and cell survival /Mitchell, Clint, January 2006 (has links)
Thesis (Ph. D.)--Virginia Commonwealth University, 2006. / Prepared for: Dept. of Biomedical Engineering. Bibliography: leaves 202-220. Also available online.
|
2 |
Zwei Fälle von Nierensarkom, ein Beitrag zur Frage der Reflexanurie ...Schoen, Rudolf January 1899 (has links)
Inaugural dissertation.--Universität Greifswald, 1899.
|
3 |
Renal cell carcinoma : factors of importance for follow-up and survival /Iranparvar Alamdari, Farhood, January 2007 (has links)
Diss. (sammanfattning) Umeå : Univ., 2007. / Härtill 4 uppsatser.
|
4 |
Angiogenesis in childhood malignancies /Sköldenberg, Erik, January 2003 (has links)
Diss. Uppsala : Univ., 2003.
|
5 |
Occlusion of arterial supply to hepatic and renal tumours an experimental and clinical investigation /Stigsson, Leif. January 1981 (has links)
Thesis (doctoral)--University of Lund, 1981. / Includes bibliographical references.
|
6 |
Dados anatômicos preditivos de desfechos cirúrgicos em nefrectomia parcial por tumor: análise prospectiva do escore R.E.N.A.L. / Accuracy of anatomic data in predict perioperative outcomes in tumor partial nephrectomy: a prospective analisis of R.E.N.A.L. nephrometry scoreCosta-Matos, André 04 August 2016 (has links)
Introdução: A nefrometria tem sido utilizada para avaliação de complexidade anatômica de tumores renais desde 2009. Foram descritos 03 escores para classificar a complexidade anatômica das massas renais: R.E.N.A.L.; PADUA; c-Index. Esses escores foram propostos em casuísticas de nefrectomia parcial (aberta, laparoscópica ou robótica) com caráter retrospectivo, assim fatores de confusão podem explicar os resultados observados na literatura. Objetivo: Testar a acurácia do escore R.E.N.A.L. em predizer desfechos perioperatórios no tratamento cirúrgico de tumors renais < 7,0cm em um modelo prospectivo. Métodos: Entre janeiro de 2010 a junho de 2012, 320 pacientes foram submetidos ao tratamento cirúrgico de tumores renais no Instituto do Câncer do Estado de São Paulo. Desses, 173(54,1%) tinham tumores < 7 cm e 71(41%) foram estudados de acordo com os critérios de inclusão e exclusão. Foram avaliados a acurárica do escore R.E.N.A.L. em prever desfechos perioperatórios (tempo de isquemia; tempo operatório; perda sanguínea; taxa de conversão para cirurgia aberta ou totalização da nefrectomia; complicações; tempo de internação e margem cirúrgica), em nefrectomias parciais com uso de curvas ROC, análises uni e multivariadas. Resultados: Nenhum paciente no grupo de baixa complexidade (BC) apresentou tempo de isquemia >20 minutos, contra 12(41,4%) e 9 (64,3%), respectivamente nos grupos de media complexidade (MC) e alta complexidade (AC) (p=0,03); porém com acurácia não significativa: AUC=0,643 (p=0,07). O escore R.E.N.A.L. se associou a taxa de conversão (BC:28,6%; MC:47,6%; AC:77,3%, p=0,02). Pacientes com escore < 8 foram mais frequentemente submetidos a nefrectomia parcial (93% vs. 72%, p=0,03) e nefrectomia parcial videolaparoscópica (56,8% vs. 28%, p=0,02), com boa acurácia: AUC=0,715;(p=0,002). O escore R.E.N.A.L. também foi associado a tempo operatório. Pacientes com escore > 8 tiveram 6,06 vezes mais chances de terem tempo cirúrgico > 180 min. (p=0,017), AUC de 0,63 (p=0,059). O escore R.E.N.A.L. não se correlacionou com sangramento, complicações (Clavien > 3), tempo de internação ou margem Resumo cirúgica comprometida. Conclusões: O escore R.E.N.A.L., nesta casuística, mostrou-se ser bom método para prever acesso cirúrgico e tipo de nefrectomia; e também se correlacionou com tempo cirúrgico e de isquemia, porém com acurácias baixas. Entretanto, o escore R.E.N.A.L. não se associou a Clavien > 3, sangramento, dias de internação ou margens cirúrgicas comprometidas / Background and Purpose: The R.E.N.A.L. nephrometry score (RNS) has been validated in multiple open, laparoscopic and robotic partial nephrectomy series. However, those studies are most retrospective and confounding factors could explain the results. The aim of this study was to test the accuracy of RNS in predicting perioperative outcomes in surgical treatment of kidney tumors < 7,0cm (T1b) in a prospective model. Methods: Between January 2010 and June 2012, 320 patients underwent radical or partial nephrectomy at our institution for the treatment of renal cancer. Of these, 173(54,1%) patients had a tumor < 7 cm, 71 patients (41%) were selected according to the inclusion and exclusion criteria and included in the prospective study. We evaluate the accuracy of the score in predicting perioperative outcomes (WIT, OT, EBL, conversion rate and complications) in partial nephrectomy using ROC curve, univariate and multivariate analyses. Results: No patients in low complexity (LC) group had WIT > 20 min, versus 12(41,4%) and 9(64,3%) in medium complexity (MC) and high complexity (HC) groups respectively (p=0,03) however with no significant accuracy: AUC=0,643 (p=0,07). RNS was associated with convertion rate (LC:28,6% ; MC:47,6%; HC:77,3%, p= 0,02). Patients with RNS < 8 were most often subjected to partial nephrectomy (93% x 72%, p=0,03) and laparoscopic partial nephrectomy (56,8% x 28%, p 0,02), with good accuracy: AUC=0,715 (p=0,002). The RNS was also associated with operative time. Patients with a score >8 had 6.06 times greater chance of having a surgery duration > 180 min. (p=0,017), AUC=0,63 (p=0,059). R.E.N.A.L. score did not correlate with EBL, complications (Clavien > 3), LOS or positive surgical margin. Conclusion: R.E.N.A.L. score, in this data, was a good method in predicting surgical access route and type of nephrectomy. Also was associated with OT and WIT, but with weak accuracy. Although, RNS was not associated with Clavien > 3, EBL, LOS or positive surgical margin
|
7 |
Proteomic studies on Cordyceps and characterization of its anti-proliferation effect on kidney cancer cells.January 2008 (has links)
Lai, Sze Tsai. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 94-104). / Abstracts in English and Chinese. / Thesis Committees --- p.i / Statement --- p.ii / Abstract --- p.iii / 摘要 --- p.v / Acknowledgments --- p.vi / List of Abbreviations --- p.vii / Table of Contents --- p.ix / List of Tables --- p.xiii / List of Figures --- p.xiv / Chapter 1 --- Literature review --- p.1 / Chapter 1.1 --- Introduction to Cordyceps --- p.1 / Chapter 1.2 --- Fungal proteomics --- p.2 / Chapter 1.2.1 --- Extraction method --- p.2 / Chapter 1.2.2 --- Proteomic study of Cordyceps --- p.3 / Chapter 1.3 --- Ingredients of Cordyceps and their related biological activities --- p.5 / Chapter 1.3.1 --- Polysaccharides --- p.5 / Chapter 1.3.2 --- Nucleosides --- p.6 / Chapter 1.3.2.1 --- Cordycepin --- p.6 / Chapter 1.3.2.2 --- Adenosine --- p.8 / Chapter 1.4 --- Cordyceps and their related biological activities --- p.9 / Chapter 1.4.1 --- Cordyceps militaris --- p.9 / Chapter 1.4.2 --- Cordyceps sinensis --- p.10 / Chapter 1.5 --- Proteomic analysis of proteome change --- p.12 / Chapter 1.5.1 --- Proteomic tools used to study the change in protein expression --- p.12 / Chapter 1.5.2 --- Two-dimensional gel electrophoresis --- p.13 / Chapter 1.5.3 --- Mass spectrometry --- p.13 / Chapter 1.6 --- Objective --- p.16 / Chapter 2 --- Methodology --- p.17 / Chapter 2.1 --- Cultivation of Cordyceps militaris --- p.17 / Chapter 2.2 --- Proteomic study on Cordyceps militaris --- p.17 / Chapter 2.2.1 --- Extraction of proteins from Cordyceps militaris --- p.17 / Chapter 2.2.2 --- Protein quantification --- p.18 / Chapter 2.2.3 --- 2D Gel electrophoresis --- p.19 / Chapter 2.2.4 --- Image analysis --- p.20 / Chapter 2.2.5 --- In gel digestion and MALDI-ToF MS --- p.20 / Chapter 2.3 --- Preparation of Cordyceps extracts for anti-proliferation assay on cell lines --- p.21 / Chapter 2.3.1 --- Types of the extracts of Cordyceps --- p.21 / Chapter 2.3.2 --- Preparation of the extracts of Cordyceps --- p.21 / Chapter 2.4 --- Anti-proliferation assay on cell lines for extract screening --- p.22 / Chapter 2.4.1 --- Cell lines and culturing condition --- p.22 / Chapter 2.4.2 --- Viable cell count using trypan blue exclusion method --- p.22 / Chapter 2.4.3 --- Anti-proliferation assay on SV7 tert using MTT assay --- p.23 / Chapter 2.4.4 --- Determination of the IC5o values --- p.24 / Chapter 2.4.5 --- Statistical Analysis --- p.24 / Chapter 2.5 --- Anti-proliferation assay on other cell lines using the two screened extracts --- p.24 / Chapter 2.5.1 --- Cell lines and culturing condition --- p.24 / Chapter 2.5.2 --- "Anti-proliferation assay on on HepG2, H292, Neuro2a,WIL2-NS cells using MTT assay" --- p.25 / Chapter 2.6 --- Proteomic studies for SV7tert and Hs68 after the treatment of extracts --- p.25 / Chapter 2.6.1 --- Protein sample preparation of SV7tert and Hs68 --- p.25 / Chapter 2.6.2 --- Protein quantification --- p.26 / Chapter 2.6.3 --- 2D Gel electrophoresis --- p.26 / Chapter 2.6.4 --- Image analysis --- p.26 / Chapter 2.7 --- Western Immunoblotting --- p.26 / Chapter 2.7.1 --- Protein sample preparation of SV7tert and Hs68 --- p.26 / Chapter 2.7.2 --- SDS-PAGE --- p.27 / Chapter 2.7.3 --- Protein Blotting --- p.27 / Chapter 2.7.4 --- Membrane Blocking and Antibody Incubations --- p.28 / Chapter 2.7.5 --- Detection of Proteins --- p.28 / Chapter 3 --- Results --- p.29 / Chapter 3.1 --- Proteins identification in Cordyceps militaris --- p.29 / Chapter 3.1.1 --- 2D gel electrophoresis analysis and resolution --- p.29 / Chapter 3.1.2 --- Identification and categorization of proteins of mycelia and fruiting body of Cordyceps militaris --- p.30 / Chapter 3.2 --- Investigation of anti-proliferating activity of extracts using MTT assays on SV7tert and Hs68 cell lines --- p.44 / Chapter 3.2.1 --- Mycelia extract from Cordyceps militaris --- p.44 / Chapter 3.2.2 --- Fruiting body extract from Cordyceps militaris --- p.44 / Chapter 3.2.3 --- Mycelia extract from Cordyceps sinensis --- p.47 / Chapter 3.2.4 --- Fruiting body extract from Cordyceps sinensis --- p.47 / Chapter 3.2.5 --- Screening of extracts --- p.50 / Chapter 3.3 --- "Investigation of anti-proliferating activity of extracts using MTT assays on HepG2,H292, Neuro2a and WIL2-NS cell lines" --- p.51 / Chapter 3.3.1 --- Mycelia extract from Cordyceps militaris --- p.51 / Chapter 3.3.2 --- Fruiting body extract from Cordyceps militaris --- p.51 / Chapter 3.4 --- Changes in total protein expression profiles in SV7tert and Hs68 cell lines --- p.56 / Chapter 3.4.1 --- Corresponding extract treatment of cell lines --- p.56 / Chapter 3.4.2 --- 2D gel electrophoresis analysis of protein from cells (SV7tert or Hs68) --- p.56 / Chapter 3.4.2.1 --- SV7tert study --- p.57 / Chapter 3.4.2.2 --- Hs68 study --- p.57 / Chapter 3.4.3 --- Protein identification --- p.65 / Chapter 3.4.3.1 --- Changes in protein expressions in SV7tert after mycelia extract treatment --- p.65 / Chapter 3.4.3.2 --- Changes in protein expressions in Hs68 after mycelia extract treatment --- p.65 / Chapter 3.4.3.3 --- Changes in protein expressions in SV7tert after fruiting body extract treatment --- p.66 / Chapter 3.4.3.4 --- Changes in protein expressions in Hs68 after fruiting body extract treatment --- p.66 / Chapter 3.5 --- Western immunoblotting --- p.71 / Chapter 3.5.1 --- Corresponding extract treatment of cell lines --- p.71 / Chapter 3.5.2 --- Normalization of protein loading using anti-actin antibody --- p.73 / Chapter 3.5.3 --- Detection of caspase 3 by use of antibody --- p.74 / Chapter 3.5.4 --- Detection of cleaved caspase 3 by use of antibody --- p.74 / Chapter 4 --- Discussion --- p.77 / Chapter 4.1 --- Identification of proteins in Cordyceps militaris --- p.77 / Chapter 4.2 --- Difficulties in identifying the proteins in Cordyceps militaris --- p.80 / Chapter 4.3 --- Investigation of anti-proliferating activity of extracts --- p.80 / Chapter 4.4 --- Changes in cell total protein expression profiles in SV7tert and Hs68 cell lines --- p.81 / Chapter 4.4.1 --- Protein alterations in SV7tert treated with mycelia extract --- p.82 / Chapter 4.4.1.1 --- Heat shock protein 27 (Hsp27) --- p.82 / Chapter 4.4.1.2 --- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) --- p.83 / Chapter 4.4.2 --- Protein alterations in Hs68 with mycelia extract treatment --- p.84 / Chapter 4.4.2.1 --- Chain B of triosephosphate isomerase - Triosephophate isomerase 1 --- p.84 / Chapter 4.4.2.2 --- Glutathione transferase --- p.85 / Chapter 4.4.3 --- Protein alterations in SV7tert with fruiting body extract treatment --- p.86 / Chapter 4.4.3.1 --- Calreticulin precusor --- p.86 / Chapter 4.4.3.2 --- Nucleophosmin 1 isoform 2 (B23) --- p.87 / Chapter 4.4.3.3 --- Heat shock 70kDa protein 8 isoform 1 - Heat shock 70kDa protein (Hsp70) --- p.88 / Chapter 4.4.3.4 --- Voltage-dependent anion channel 2 (VDAC2) --- p.89 / Chapter 4.4.3.5 --- "Tumor protein, translationally controlled (TCTP)" --- p.90 / Chapter 4.4.3.6 --- RAN binding protein 1 (RANBP1) --- p.91 / Chapter 4.4.4 --- Protein alteration in Hs68 with mycelia extract treatment --- p.92 / Chapter 4.5 --- Conclusion --- p.93 / References --- p.94
|
8 |
Molecular genetic aspects of renal cell carcinoma development /Alimov, Andrei, January 2003 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 6 uppsatser.
|
9 |
Diet and renal cell carcinoma /Rashidkhani, Bahram, January 2005 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2005. / Härtill 4 uppsatser.
|
10 |
Tracking functional changes in the cancer genome : a molecular genetic analysis of renal and prostatic carcinomas using PCR based techniques by a candidate chromosome and candidate gene approach /Li, Chunde, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 6 uppsatser.
|
Page generated in 0.0562 seconds